Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Planet Labs PBC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2020
FY2022
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
95.7
113
131
191
221
244
308
Cost of revenue
102
87.4
83
97.2
108
105
135
Gross profit
-6.66
25.8
48.2
94
113
140
172
Research and development
37.9
43.8
66.7
111
116
101
107
Selling and marketing
34.9
37.3
52.9
78
86.3
77.7
72.7
General and administrative
27
32.1
56.7
80.7
80.1
77.1
88.1
Operating expenses
99.8
113
176
270
283
256
268
Operating income
-106
-87.4
-128
-176
-170
-116
-95.1
Interest expense
6.95
9.45
8.77
0
0
0.83
3.44
Interest income
0.05
0.02
7.67
15.4
10.3
14.3
Other non-operating income
-17.1
-38.6
-6.96
14.6
30.1
-4.61
-147
Pre-tax income
-124
-126
-135
-161
-140
-121
-242
Income tax
0.13
1.07
2.11
0.85
0.82
2.46
4.66
Net income
-124
-127
-137
-162
-141
-123
-247
EBITDA
-28.8
-25.2
-83
-132
-122
-70.5
-53.2
EPS, basic
-2.89
-2.87
-1.72
-0.61
-0.50
-0.42
-0.80
EPS, diluted
-2.89
-2.87
-1.72
-0.61
-0.50
-0.42
-0.80
Shares, basic (weighted)
42.9
44.2
79.6
267
280
292
308
Shares, diluted (weighted)
42.9
44.2
79.6
267
280
292
308
Balance sheet
FY2020
FY2022
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
27.7
71.2
491
182
83.9
118
229
Short-term investments
0
227
215
104
411
Receivables
47.1
44.4
39
43.3
55.8
83.5
Inventory
0
6.12
Other current assets
7.13
16.4
27.4
19.6
17.7
45
Total current assets
125
552
476
370
302
775
Property, plant and equipment
160
133
108
113
122
151
Lease right-of-use assets
0
20.4
22.3
19.8
14.6
Goodwill
88.4
88.4
103
113
136
136
143
Intangible assets
5.67
14.2
14.8
32.4
27.5
26.6
Other non-current assets
2.98
2.71
3.92
2.43
1.95
8.13
Total assets
399
821
753
702
634
1,146
Accounts payable
1.45
2.85
6.9
2.6
2.6
10.6
Accrued liabilities
3.23
6.01
8.52
6.86
8.06
13.9
Deferred revenue
57.6
64.2
51.9
72.3
82.3
221
Total current liabilities
109
132
122
137
142
469
Lease liabilities
0
17.1
17
12.4
8.3
Other non-current liabilities
1.29
1.41
1.49
9.14
0.53
1.06
Total liabilities
292
173
177
184
193
957
Paid-in capital
746
1,423
1,513
1,596
1,645
1,632
Retained earnings
-640
-777
-939
-1,080
-1,203
-1,450
Other comprehensive income
1.77
2.1
2.27
1.59
-1.1
6.36
Shareholders' equity
218
108
648
576
518
441
188
Total equity
218
108
648
576
518
441
188
Total liabilities and equity
399
821
753
702
634
1,146
Cash flow statement
FY2020
FY2022
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-124
-127
-137
-162
-141
-123
-247
Depreciation and amortization
77.6
62.2
45
43.3
47.6
45.6
41.8
Stock-based compensation
5.07
14
42
75.5
57.1
48.5
55
Deferred income tax
-0.4
-0.05
-1.39
-0.46
0.15
0.1
0.06
Change in receivables
8.96
-19.9
3.26
6.31
-2.66
-12
-30.2
Change in inventory
0
0
-0.61
Change in payables
3.07
11
16.1
-2.99
-25
-13.3
13.8
Cash from operations
-33.7
-4.03
-42.2
-73.9
-50.7
-14.4
134
Capital expenditures
-16.7
-26.1
-10.3
-10.4
-38
-44.3
-76.7
Acquisitions
-2.46
0
-9.62
-3.82
-7.54
-1.07
-5.4
Purchases of investments
0
0
-280
-189
-140
-428
Sales and maturities of investments
0
55.2
161
61.4
90
Cash from investing
-27.2
-30.8
-25.1
-242
-33.6
57.9
-393
Stock issued
0.26
0.54
10.6
14.7
7.39
4.38
27.7
Cash from financing
8.73
83.9
489
7.86
-1.6
-15.5
357
Exchange rate effect
-0.04
-0.31
-1.55
-0.4
0.02
-0.2
7.26
Net change in cash
-52.2
48.8
420
-309
-85.9
27.8
106
Free cash flow
-50.4
-30.1
-52.5
-84.4
-88.7
-58.7
57.6
Interest paid
5.54
6.55
6.75
0
0
Income taxes paid
0
1.08
0.88
3.1
0.2
1.8
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $17.43 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
55.4%
Gross profit / revenue.
Operating margin
-27.2%
Operating income / revenue.
EBITDA margin
-17.4%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-93.8%
Pre-tax income / revenue.
Net margin
-95.1%
Net income / revenue.
FCF margin
6.5%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
31.1%
Cash from operations / revenue.
Return on equity (ROE)
-63.8%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-25.1%
Net income / average total assets.
Return on invested capital (ROIC)
-54.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
33.9%
Research and development expense / revenue.
Stock-based pay / revenue
16.5%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
24.6%
Capital expenditures / revenue.
D&A / revenue
9.7%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
25.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
17.2%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
22.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
23.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
22.4%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
46.2%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-57.3%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-31.1%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
11.9%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
80.8%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
15.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
23.5%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
5.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
4.8%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
47.4%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.84x
Current assets / current liabilities.
Quick ratio
2.63x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
2.46x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Capex / operating cash flow
79.0%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.00
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.05
Revenue / diluted weighted shares.
FCF per share
$0.07
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.33
Cash from operations / diluted weighted shares.
Book value per share
$1.57
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
16.4x
Market cap / revenue.
P/B
11.0x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
15.8x
Market cap / tangible book value, when positive.
P/FCF
252x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
52.8x
Market cap / cash from operations, when positive.
EV/Sales
14.1x
Enterprise value / revenue.
EV/FCF
217x
Enterprise value / free cash flow, when both are positive.
FCF yield
0.4%
Free cash flow / market cap.
Earnings yield
-5.8%
Net income / market cap (the inverse of P/E).
What was Planet Labs PBC's revenue in fiscal 2026?
Planet Labs PBC reported revenue of $307.7M for fiscal 2026, 25.9% higher than the year before.
Was Planet Labs PBC profitable in fiscal 2026?
No. It reported a net loss of $246.9M.
How much free cash flow did Planet Labs PBC generate in fiscal 2026?
Cash from operations of $134.4M minus capital expenditures of $76.7M left free cash flow of $57.6M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.